Trials / Sponsors / BIND Therapeutics
BIND Therapeutics
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Ce Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer | Phase 2 | 2015-06-01 |
| Completed | A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients Wi KRAS Positive Patients With Non-small Cell Lung Cancer, Squamous Cell Non-small Cell Lung Cancer | Phase 2 | 2014-09-01 |
| Completed | A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspe Non-small Cell Lung Cancer | Phase 2 | 2013-04-01 |
| Completed | A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspe CRPC, Prostate Cancer | Phase 2 | 2013-04-01 |
| Completed | A Study of BIND-014 Given to Patients With Advanced or Metastatic Cancer Metastatic Cancer, Cancer, Solid Tumors | Phase 1 | 2011-01-01 |